Stock listing

Rigel Pharmaceuticals, Inc.

Selected listing: A40EFY · LS · EUR · DE

Rigel Pharmaceuticals, Inc. (Lang & Schwarz: A40EFY), Health Technology. Latest release Oct 2, 2026: Rigel Pharmaceuticals, Inc. Announces Inducement Grants…

A40EFY:LSEURDEUpdated September 25, 2026

Ticker: Lang & Schwarz: A40EFY
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Lang & Schwarz
Currency: EUR

About Rigel Pharmaceuticals, Inc.

The company focuses on the development of innovative therapies for various diseases. Rigel is dedicated to advancing its pipeline of drug candidates to address unmet medical needs.

Latest news from Rigel Pharmaceuticals, Inc.

Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

October 1, 2026

Rigel Announces Availability of VEPPANU™ (vepdegestrant) for Patients with ER+/HER2-, ESR1-Mutated Advanced or Metastatic Breast Cancer

August 10, 2026

Rigel Reports Second Quarter 2026 Financial Results

August 4, 2026

Onco360® Has Been Selected as a National Pharmacy Partner for VEPPANU™ (vepdegestrant)

July 29, 2026

Rigel Announces Conference Call and Webcast to Report Second Quarter 2026 Financial Results

July 28, 2026

All Rigel Pharmaceuticals, Inc. news →

Events

Replays

Rigel Pharmaceuticals, Inc. (RIGL) Q2 2026 Earnings Call
Tue, Aug 04, 2026 · 04:30 PM ET
Watch
Rigel Pharmaceuticals, Inc. (RIGL) Q1 2026 Earnings Call
Tue, May 05, 2026 · 04:30 PM ET
Watch
Rigel Pharmaceuticals, Inc. (RIGL) Q4 2025 Earnings Call
Tue, Mar 03, 2026 · 04:30 PM ET
Watch

Research Rigel Pharmaceuticals, Inc.

Rigel Pharmaceuticals, Inc. company profile

View the public company page for Rigel Pharmaceuticals, Inc. on 6ix.

Rigel Pharmaceuticals, Inc. news

Read company news and market updates connected to Rigel Pharmaceuticals, Inc..

Rigel Pharmaceuticals, Inc. investor events

Find investor webinars, events, and replay context for Rigel Pharmaceuticals, Inc..